EXCLUSIVE: FENIX Interview with CGM Newcomer Allez Health (Part 2)
As promised, FENIX delivers on Part 2 of the exclusive interview with Leif Bowman, the co-founder of Allez Health, an emerging biosensor venture founded by veterans in the CGM space. In case you missed it, Part 1 of the exclusive interview covered insights into Allez’s business philosophy and an early look into the features of its CGM (view here). Below, FENIX provides further details on Allez’s launch timelines, data-sharing strategy, and perspective on the market heavyweights, Dexcom and Abbott.
About The Author
Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.
If you receive our email blasts, you already have an account. Log in now
You can read the article’s full content online after purchase.